BioSpace News Archive

Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced the presentation of positive findings from a previously reported investigational study that used thermography technology to assess the pharmacodynamics of Sildenafil Cream, 3.6% (Sildenafil Cream) in healthy women.

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, announces the approval of its Investigational New Drug (“IND”) application by the United States Food and Drug Administration (“FDA”) for eftilagimod alpha (“efti” or “IMP321”).

Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the “Company”) announced today the completion of its merger with Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix”) following the satisfaction of all closing conditions required by the merger agreement.

Expects Delivery and Sales of Initial RAP Devices for Tattoo Removal in Mid-2020

Bain & Company’s ninth Global Healthcare Private Equity and Corporate M&A Report follows developments in the sector as global markets prepare for a slowdown

Nanoform, an innovative nanoparticle medicine enabling company, and Orion Corporation, a Finnish pharmaceutical company, announced a collaboration to apply Nanoform’s award-winning CESS® technology to new chemical entities.

Zydus gains exclusive rights to develop and commercialize XOMA’s IL-2 antibody

Avellino announced that its newly developed coronavirus diagnostic test has been validated pursuant to the policy for diagnostics testing during a public health emergency of the United States Food and Drug Administration pending the FDA’s independent review.

Sick of being pushed around by giant pharmacy benefit managers, independent pharmacies are taking matters into their own hands, founding a newly licensed health insurance company and debuting a patient-centered, pharmacy-friendly Medicare-D plan this fall.

Lannett Company, Inc. announced that the company will present at the 32nd Annual ROTH Conference on March 16, 2020 at 2:30 p.m. PT at The Ritz Carlton, in Laguna Niguel, California.